![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Marijuana has been proposed as treatment for a widening spectrum of medical conditions. Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). These include analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction. In addition, marijuana has now been shown to have strong antioxidative and neuroprotective effects, which may prolong neuronal cell survival. In areas where it is legal to do so, marijuana should be considered in the pharmacological management of ALS. Further investigation into the usefulness of marijuana in this setting is warranted.
Keywords
|
Grinspoon L , Bakalar JB : Marihuana, the Forbidden Medicine. New Haven: Yale University Press, 1993. Google Scholar | |
|
Hollister LE : Interactions of cannabis with other drugs in man. In Braude MC , Ginzburg HM (eds.): Strategies for Research on the Interactions of Drugs of Abuse. National Institute on Drug Abuse Research Monograph 68. DHHS Pub. No. (ADM)86-1453. Washington, DC: Government Printing Office, 1986: 110-116. Google Scholar | |
|
Institute of Medicine : Division of Health Sciences Policy. Marijuana and Health: Report of a Study by a Committee of the Institute of Medicine, Division of Health Sciences Policy. Washington, DC: National Academy Press, 1982. Google Scholar | |
|
Public Health Service, Food and Drug Administration : FDA Guideline for the Clinical Evaluation of Analgesic Drugs. DHHS Pub. No. 93-3093. Rockville, MD: United States Department of Health and Human Services, 1992. Google Scholar | |
|
Beal JE , Olson DO , Laubenstein L , et al. : Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain & Symptom Management. 1995; 10: 89-97. Google Scholar | Crossref | Medline | |
|
Foltin RW , Fischman MW , Byrne MF : Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite. 1988; 11: 1-14. Google Scholar | Crossref | Medline | ISI | |
|
Greenberg I , Kuehnle J , Mendelson JH , Bernstein JG : Effects of marijuana use on body weight and caloric intake in humans. Psychopharmacology. 1976; 49: 79-84. Google Scholar | Medline | |
|
Nelson K , Walsh D , Deeter P , Sheehan F : A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliative Care. 1994; 10(1): 14-18. Google Scholar | SAGE Journals | |
|
Adams IB , Martin BR : Cannabis: Pharmacology and toxicology in animals and humans. Addiction. 1996; 91(11): 1585-1614. Google Scholar | Crossref | Medline | ISI | |
|
Agurell S , Halldin M , Lindgren JE , et al. : Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev. 1986; 38(1): 21-43. Google Scholar | Medline | |
|
Johansson E , Halldin MM , Agurell S , et al. : Terminal elimination plasma half-life of delta-1-tetrahydrocannabinol (delta-1-THC) in heavy users of marijuana. Eur J Clin Pharmacol. 1989; 37(3): 273-277. Google Scholar | Crossref | Medline | |
|
Thomas BF , Adams IB , Mascarella SW , et al. : Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore. J Med Chem. 1996; 39(2): 471-497. Google Scholar | Crossref | Medline | ISI | |
|
Mechoulam R , Devane WA , Breuer A , Zahalka J : A random walk through a cannabis field. Special Issue: Pharmacological, chemical, biochemical and behavioral research on cannabis and the cannabinoids. Pharmacol Biochem Behav. 1991; 40(3): 461-464. Google Scholar | Crossref | Medline | ISI | |
|
Conrad C : Hemp for Health: The Medicinal and Nutritional Uses of Cannabis Sativa. Rochester, VT: Healing Arts Press, 1997. Google Scholar | |
|
Jones RT : Drug of abuse profile: Cannabis. Clin Chem. 1987; 33(11 Suppl): 72B-81B. Google Scholar | Medline | ISI | |
|
Jones RT , Benowitz NL , Herning RI : Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol. 1981; 21: 143S-152S. Google Scholar | Crossref | Medline | ISI | |
|
Polen MR , Sidney S , Tekawa IS , et al. : Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med. 1993; 158(6): 596-601. Google Scholar | Medline | |
|
Pope HG , Yurgelun-Todd D : The residual cognitive effects of heavy marijuana use in college students. JAMA. 1996; 275(7): 521-527. Google Scholar | Crossref | Medline | ISI | |
|
Klein TW , Lane B , Newton CA , Friedman H : The cannabinoid system and cytokine network. Proc Soc Exp Biol Med. 2000; 225(1): 1-8. Google Scholar | Crossref | Medline | ISI | |
|
Pertwee RG : Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Investig Drugs. 2000; 9(7): 1553-1571. Google Scholar | Crossref | Medline | ISI | |
|
Akinshola BE , Chakrabarti A , Onaivi ES : In-vitro and in-vivo action of cannabinoids. Neurochem Res. 1999; 24(10): 1233-1240. Google Scholar | Crossref | Medline | |
|
DiMarzo M , Bisogno T , DePetrocellis L : Endocannabinoids: New targets for drug development. Curr Pharm Des. 2000; 6(13): 1361-1380. Google Scholar | Crossref | Medline | |
|
Carter GT : Rehabilitation management of neuromuscular disease. J Neuro Rehab. 1997; 11(2): 1-12. Google Scholar | |
|
Carter GT , Miller RG : Comprehensive management of amyotrophic lateral sclerosis. Physical Medicine & Rehabilitation Clinics of North America. Philadelphia: W.B. Saunders, 1998: 227-284. Google Scholar | Crossref | |
|
Carter GT , Johnson ER , Bonekat HW , Lieberman JS : Laryngeal diversion in the treatment of intractable aspiration in motor neuron disease. Arch Phys Med Rehabil. 1992; 73(7): 680-682. Google Scholar | Medline | ISI | |
|
Carter GT : Neuromuscular disorders. In Dell Orto AE , Marinelli RP (eds.): Encyclopedia of Disability and Rehabilitation. New York: Macmillan, 1995: 509-515. Google Scholar | |
|
Miller RG , Rosenberg JA , Gelinas DF , et al. : Practice parameter: The care of patients with amyotrophic lateral sclerosis (an evidence-based review). Muscle Nerve. 1999; 22: 1104-1118. Google Scholar | Crossref | Medline | |
|
Fowler WM , Carter GT , Kraft GH : Role of physiatry in the management of neuromuscular disease. Phys Med Rehabil Clin N Am 1998; 9(1): 1-8. Google Scholar | Crossref | Medline | |
|
Klivenyi P , Ferrante RJ , et al. : Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med. 1999; 5(3): 347-350. Google Scholar | Crossref | Medline | |
|
Tarnopolsky M , Martin J : Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology. 1999; 52: 854-857. Google Scholar | Crossref | Medline | |
|
Abresch RT , Seyden NK , Wineinger MA : Quality of life: Issues for persons with neuromuscular diseases. Physical Medicine & Rehabilitation Clinics of North America. Philadelphia: W.B. Saunders, 1998: 233-248. Google Scholar | |
|
Hillard CJ : Endocannabinoids and vascular function. J Pharmacol Exp Ther. 2000; 294(1): 27-32. Google Scholar | Medline | |
|
Meng ID , Manning BH , Martin WJ , Fields HL : An analgesia circuit activated by cannabinoids. Nature. 1998; 395(6700): 381-383. Google Scholar | Crossref | Medline | ISI | |
|
Harvey DJ (ed.): Marihuana, ‘84: Satellite Symposium on Cannabis: Proceedings of the Oxford Symposium on Cannabis. Washington, DC: IRL Press, 1985: 45-54. Google Scholar | |
|
Rueda D , Galve-Roperh I , Haro A , Guzman M : The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol. 2000; 58(4): 814-820. Google Scholar | Crossref | Medline | |
|
Noyes R , Brunk SF , Baram DA , Canter AC : Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol. 1975; 15(2-3): 139-143. Google Scholar | Crossref | Medline | ISI | |
|
Zeltser R , Seltzer Z , Eisen A , et al. : Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain. 1991; 47(1): 95-103. Google Scholar | Crossref | Medline | ISI | |
|
Noyes R , Brunk SF , Avery DAH , Canter AC : The analgesic properties of delta-9-tetrahydrocannabinol. Clin Pharmacol Ther. 1975; 18(1): 84-89. Google Scholar | Crossref | Medline | ISI | |
|
Raft D , Gregg J , Ghia J , Harris L : Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Clin Pharmacol Ther. 1977; 21(1): 26-33. Google Scholar | Crossref | Medline | |
|
Carter GT , Butler LM , Abresch RT , Ugalde VO : Expanding the role of hospice in the care of amyotrophic lateral sclerosis. American J Hospice & Palliative Care. 1999; 16(6): 707-710. Google Scholar | SAGE Journals | |
|
Mclaughlin PJ , Delevan CE , Carnicom S , et al. : Fine motor control in rats is disrupted by delta -9-tetrahydrocannabinol. Pharmacol Biochem Behav. 2000; 66(4): 803-809. Google Scholar | Crossref | Medline | |
|
Herkenham M : Cannabinoid receptor localization in brain: Relationship to motor and reward systems. In Kalivas PW , Samson HH (eds.): The neurobiology of drug and alcohol addiction. Google Scholar Ann NY Acad Sci. 1992; 654: 19-32. Google Scholar | Crossref | Medline | |
|
Richardson JD : Cannabinoids modulate pain by multiple mechanisms of action. J Pain. 2000; 1(1): 1-20. Google Scholar | Crossref | ISI | |
|
Meinck HM , Schonle PW , Conrad B : Effects of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol. 1989; 263(2): 120-122. Google Scholar | Crossref | ISI | |
|
Greenberg HS , Weiness AS , Pugh JE : Short term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharmacol Ther. 1994; 55: 324-328. Google Scholar | Crossref | Medline | ISI | |
|
Hollister LE : Health aspects of cannabis. Pharmacol Rev. 1986; 38(1): 1-20. Google Scholar | Medline | |
|
Plasse TF , Gorter RW , Krasnow SH , et al. : Recent clinical experience with dronabinol. Pharmacol Biochem Behav. 1991; 40: 695-700. Google Scholar | Crossref | Medline | ISI | |
|
Lichtman AH , Peart J , Poklis JL , et al. : Pharmacological evaluation of aerosolized cannabinoids in mice. Eur J Pharmacol. 2000; 399(2-3): 141-149. Google Scholar | Crossref | Medline | |
|
Kelly P , Jones RT : Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol. 1992; 16: 228-235. Google Scholar | Crossref | Medline | |
|
Jones RT : Cardiovascular effects of cannabinoids. In Harvey DJ (ed.): Marihuana, ‘84: Satellite Symposium on Cannabis: Proceedings of the Oxford Symposium on Cannabis. Oxford: IRL Press, 1985: 325-334. Google Scholar | |
|
Barnett G , Licko V , Thompson T : Behavioral pharmacokinetics of marijuana. Psychopharmacology. 1985; 85(1): 51-56. Google Scholar | Crossref | Medline | |
|
Heishman SJ , Stitzer ML , Yingling JE : Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav. 1989; 34(1): 173-179. Google Scholar | Crossref | Medline | |
|
Benowitz NL , Nguyen T , Jones RT , et al. : Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction. Clin Pharmacol Ther. 1980; 28: 115-120. Google Scholar | Crossref | Medline | |
|
Herning RI , Hooker WD , Jones RT : Tetrahydrocannabinol content and differences in marijuana smoking behavior. Psychopharmacology. 1986; 90(2): 160-162. Google Scholar | Crossref | Medline | |
|
Huestis MA , Henningfield JE , Cone EJ : Blood cannabinoids, Pt 1: Absorption of THC and formation of 11-OH-THC and THC COOH during and after smoking marijuana. J Anal Toxicol. 1992; 16(5): 276-282. Google Scholar | Crossref | Medline | |
|
Huestis MA , Sampson AH , Holicky BJ , et al. : Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther. 1992; 52(1): 31-41. Google Scholar | Crossref | Medline | |
|
Gruber AJ , Pope HG : Cannabis psychotic disorder: Does it exist? Am J Addict. 1994; 3(1): 72-83. Google Scholar | |
|
Benowitz NL , Jones RT : Effect of delta-9-tetrahydrocannabinol on drug distribution and metabolism: Antipyrine, pentobarbital and ethanol. Clin Pharmacol Ther. 1977; 22(3): 259-268. Google Scholar | Crossref | Medline | |
|
Benowitz NL , Jones RT : Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. J Clin Pharmacol. 1981; 21: 214S-223S. Google Scholar | Crossref | Medline | |
|
Hampson AJ , Grimaldi M , Axelrod J , Wink D : Cannabidiol and delta-9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci. 1998; 95(14): 8268-8273. Google Scholar | Crossref | Medline | |
|
Hampson AJ , Grimaldi M , Lolic M , et al. : Neuroprotective antioxidants from marijuana. Ann NY Acad Sci. 2000; 899: 274-282. Google Scholar | Crossref | Medline | ISI | |
|
Nagayama T , Sinor AD , Simon RP , et al. : Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci. 1999; 19(8): 2987-2995. Google Scholar | Crossref | Medline | ISI | |
|
Chen Y , Buck J : Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther. 2000; 293(3): 807-812. Google Scholar | Medline | ISI | |
|
Eshhar N , Striem S , Biegon A : HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture. Neuroreport. 1993; 5(3): 237-240. Google Scholar | Crossref | Medline | ISI | |
|
Hollister LE : Marijuana and immunity. J Psychoactive Drugs. 1988; 20(1): 3-8. Google Scholar | Crossref | Medline | |
|
Friedman H , Klein TW , Newton C , Daaka Y : Marijuana, receptors and immunomodulation. Adv Exp Med Biol. 1995; 373: 103-113. Google Scholar | Crossref | Medline | |
|
Renn E , Mandel S , Mandel E : The medicinal uses of marijuana. Pharmacy & Therapeutics. 2000; 25(10): 536-524. Google Scholar | |
|
Gurley RJ , Aranow R , Katz M : Medicinal marijuana: a comprehensive review. J Psychoactive Drugs. 1998; 30(2): 137-147. Google Scholar | Crossref | Medline | ISI | |
|
Voth EA , Schwartz RH : Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann Intern Med. 1997; 126(10): 791-798. Google Scholar | Crossref | Medline | ISI | |
|
Voelker R : Medical marijuana: A trial of science and politics. JAMA. 1994; 271(1): 1647-1648. Google Scholar | |
|
Voelker R : New marijuana laws in two states prompt caution. JAMA. 1996; 276(22): 1786-1788. Google Scholar | Crossref | Medline | |
|
Landis NT : California, Arizona law permits medical use of marijuana: Police and health professionals wary about conflicts with federal law. Am J Health Syst Pharm. 1997; 54(2): 126-132. Google Scholar | Crossref | Medline | |
|
Macready N : Two more US states approve cannabis. BMJ. 1996; 313(7067): 1224. Google Scholar | Crossref | Medline | |
|
Hubbard JR , Franco SE , Onaivi ES : Marijuana: medical implications. Am Family Physician. 1999; 60(9): 2583-2588. Google Scholar | Medline | |
|
Robson P : Cannabis. Arch Dis Child. 1997; 77(2): 164-166. Google Scholar | Crossref | Medline |
